Pharmacovigilance Partner Alliance Manager
Essential Pharma
Pharmacovigilance Partner Alliance Manager
Essential Pharma
Specialty pharma acquiring legacy, at-risk drugs
Specialty pharma acquiring legacy, at-risk drugs
Essential Pharma buys mature, low-volume medicines that larger firms divest and brings them to market to keep patients covered. It acquires at-risk and legacy drugs across rare diseases, CNS, ophthalmology, and gastroenterology, then licenses, transfers, and distributes them through a global network in about 70 countries. The company differentiates itself by specializing in complex product transfers, licensing deals, and continuity of supply for essential medicines, acting as a partner for pharmaceutical divestments. Its goal is to maintain patient access to important medicines by growing the portfolio and global footprint through strategic acquisitions and licensing, including development-stage assets.
Explore more opportunities at Essential Pharma